<?xml version='1.0' encoding='utf-8'?>
<collection>
<document>
<id>
   26784937
  </id>
<passage>
<infon key="type">
    title
   </infon>
<offset>
    0
   </offset>
<text>
    NTRK fusion <z:mesh cui="C0029016" id="http://purl.bioontology.org/ontology/MESH/D009857" semantics="http://purl.bioontology.org/ontology/STY/T028">oncogenes</z:mesh> in pediatric <z:mesh cui="C0238463, C3501844, C3501843" id="http://purl.bioontology.org/ontology/MESH/D000077273" semantics="http://purl.bioontology.org/ontology/STY/T191">papillary thyroid carcinoma</z:mesh> in northeast <z:mesh cui="C0041703" id="http://purl.bioontology.org/ontology/MESH/D014481" semantics="http://purl.bioontology.org/ontology/STY/T083">United States</z:mesh>.
   </text>
</passage>
<passage>
<infon key="type">
    abstract
   </infon>
<offset>
    91
   </offset>
<text>
    BACKGROUND: An increase in <z:mesh cui="C0040136, C0549473, C0151468" id="http://purl.bioontology.org/ontology/MESH/D013964" semantics="http://purl.bioontology.org/ontology/STY/T191">thyroid cancers</z:mesh>, predominantly <z:mesh cui="C0238463, C3501844, C3501843" id="http://purl.bioontology.org/ontology/MESH/D000077273" semantics="http://purl.bioontology.org/ontology/STY/T191">papillary thyroid carcinoma</z:mesh> (PTC), has been recently reported in <z:mesh cui="C0008059" id="http://purl.bioontology.org/ontology/MESH/D002648" semantics="http://purl.bioontology.org/ontology/STY/T100">children</z:mesh>. METHODS: The <z:mesh cui="C0220797, C0205469, C0243140, C0243139" id="http://purl.bioontology.org/ontology/MESH/Q000473" semantics="http://purl.bioontology.org/ontology/STY/T169, http://purl.bioontology.org/ontology/STY/T091, http://purl.bioontology.org/ontology/STY/T033">histopathology</z:mesh> of 28 consecutive PTCs from the northeast <z:mesh cui="C0041703" id="http://purl.bioontology.org/ontology/MESH/D014481" semantics="http://purl.bioontology.org/ontology/STY/T083">United States</z:mesh> was reviewed. None of the <z:mesh cui="C0030705, C0008942" id="http://purl.bioontology.org/ontology/MESH/D010361" semantics="http://purl.bioontology.org/ontology/STY/T101, http://purl.bioontology.org/ontology/STY/T096">patients</z:mesh> (ages 6-18 years; 20 <z:mesh cui="C0086287" id="http://purl.bioontology.org/ontology/MESH/D005260" semantics="http://purl.bioontology.org/ontology/STY/T032">females</z:mesh>, 8 <z:mesh cui="C0086582" id="http://purl.bioontology.org/ontology/MESH/D008297" semantics="http://purl.bioontology.org/ontology/STY/T032">males</z:mesh>) had significant exposure to <z:mesh cui="C0851346" id="http://purl.bioontology.org/ontology/MESH/D011827" semantics="http://purl.bioontology.org/ontology/STY/T070">radiation</z:mesh>. <z:mesh cui="C0028606" id="http://purl.bioontology.org/ontology/MESH/D009696" semantics="http://purl.bioontology.org/ontology/STY/T123, http://purl.bioontology.org/ontology/STY/T114">Nucleic acid</z:mesh> from <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh> was tested for genetic <z:mesh cui="C0243070, C0243069, C0000769, C1527361, C0243066, C0000846, C0220810, C0334079, C0243067" id="http://purl.bioontology.org/ontology/MESH/Q000002" semantics="http://purl.bioontology.org/ontology/STY/T046, http://purl.bioontology.org/ontology/STY/T080, http://purl.bioontology.org/ontology/STY/T169, http://purl.bioontology.org/ontology/STY/T019">abnormalities</z:mesh> (n = 27). <z:mesh cui="C4704700" id="http://purl.bioontology.org/ontology/MESH/D000076723" semantics="http://purl.bioontology.org/ontology/STY/T185">Negative results</z:mesh> were reevaluated by targeted <z:mesh cui="C5392992, C4687476, C2732543, C2936622, C2936625, C4288871, C2936623, C2936621, C2936624" id="http://purl.bioontology.org/ontology/MESH/D059014" semantics="http://purl.bioontology.org/ontology/STY/T059, http://purl.bioontology.org/ontology/STY/T063">next-generation sequencing</z:mesh>. RESULTS: Seven of 27 PTCs (26%) had neurotrophic <z:mesh cui="C0206364" id="http://purl.bioontology.org/ontology/MESH/D020794" semantics="http://purl.bioontology.org/ontology/STY/T126, http://purl.bioontology.org/ontology/STY/T116, http://purl.bioontology.org/ontology/STY/T192">tyrosine kinase receptor</z:mesh> (NTRK) fusion <z:mesh cui="C0029016" id="http://purl.bioontology.org/ontology/MESH/D009857" semantics="http://purl.bioontology.org/ontology/STY/T028">oncogenes</z:mesh> (NTRK type 3/ets variant 6 [NTRK3/ETV6], n =5; NTRK3/unknown, n = 1; and NTRK type 1/translocated <z:mesh cui="C0033834, C0023101, C0035902, C2350877, C0013462, C0033413, C0026070" id="http://purl.bioontology.org/ontology/MESH/D011401" semantics="http://purl.bioontology.org/ontology/STY/T123, http://purl.bioontology.org/ontology/STY/T114">promoter region</z:mesh>, nuclear basket <z:mesh cui="C0033684, C0751455" id="http://purl.bioontology.org/ontology/MESH/D011506" semantics="http://purl.bioontology.org/ontology/STY/T123, http://purl.bioontology.org/ontology/STY/T116">protein</z:mesh> [NTRK1/TPR], n = 1), including 5 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh> that measured &gt;2 cm and 3 that diffusely involved the entire <z:mesh cui="C0040132" id="http://purl.bioontology.org/ontology/MESH/D013961" semantics="http://purl.bioontology.org/ontology/STY/T023">thyroid</z:mesh> or lobe. All 7 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh> had lymphatic invasion, and 5 had vascular invasion. Six of 27 PTCs (22%) had ret <z:mesh cui="C0033713" id="http://purl.bioontology.org/ontology/MESH/D011519" semantics="http://purl.bioontology.org/ontology/STY/T028">proto-oncogene</z:mesh> (RET) fusions (RET/PTC1, n = 5; RET/PTC3, n = 1); 2 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh> measured &gt;2 cm and diffusely involved the <z:mesh cui="C0040132" id="http://purl.bioontology.org/ontology/MESH/D013961" semantics="http://purl.bioontology.org/ontology/STY/T023">thyroid</z:mesh>, and 5 had lymphatic invasion, with vascular invasion in 2. Thirteen PTCs had the B-Raf <z:mesh cui="C0033713" id="http://purl.bioontology.org/ontology/MESH/D011519" semantics="http://purl.bioontology.org/ontology/STY/T028">proto-oncogene</z:mesh>, <z:mesh cui="C0036720" id="http://purl.bioontology.org/ontology/MESH/D012694" semantics="http://purl.bioontology.org/ontology/STY/T123, http://purl.bioontology.org/ontology/STY/T116, http://purl.bioontology.org/ontology/STY/T121">serine</z:mesh>/<z:mesh cui="C0072402" id="http://purl.bioontology.org/ontology/MESH/D017346" semantics="http://purl.bioontology.org/ontology/STY/T126, http://purl.bioontology.org/ontology/STY/T116">threonine kinase</z:mesh> (BRAF) <z:mesh cui="C0042285" id="http://purl.bioontology.org/ontology/MESH/D014633" semantics="http://purl.bioontology.org/ontology/STY/T123, http://purl.bioontology.org/ontology/STY/T116">valine</z:mesh>-to-<z:mesh cui="C0112117, C0061472, C0138008, C0887650, C0220839, C0376183" id="http://purl.bioontology.org/ontology/MESH/D018698" semantics="http://purl.bioontology.org/ontology/STY/T123, http://purl.bioontology.org/ontology/STY/T116, http://purl.bioontology.org/ontology/STY/T121">glutamic acid</z:mesh> <z:mesh cui="C0026882" id="http://purl.bioontology.org/ontology/MESH/D009154" semantics="http://purl.bioontology.org/ontology/STY/T045">mutation</z:mesh> at position 600 (BRAF(V) (600E)) (13 of 27 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh>; 48%), 11 measured &lt;2 cm, and 6 had lymphatic invasion (46%), with vascular invasion in 3. Fusion <z:mesh cui="C0029016" id="http://purl.bioontology.org/ontology/MESH/D009857" semantics="http://purl.bioontology.org/ontology/STY/T028">oncogene</z:mesh> <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh>, compared with BRAF(V) (600E) PTCs, were associated with large size (mean, 2.2 cm vs 1.5 cm, respectively; P = .05), solid and diffuse variants (11 of 13 vs 0 of 13 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh>, respectively; P &lt; .001), and lymphovascular invasion (12 of 13 vs 6 of 13 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh>, respectively; P = .02); BRAF(V) (600E) PTCs were predominantly the classic variant (12 of 13 vs 1 of 13 <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh>). Two <z:mesh cui="C0086692, C0006826, C0027651" id="http://purl.bioontology.org/ontology/MESH/D009369" semantics="http://purl.bioontology.org/ontology/STY/T191">tumors</z:mesh> metastasized to the <z:mesh cui="C0024109" id="http://purl.bioontology.org/ontology/MESH/D008168" semantics="http://purl.bioontology.org/ontology/STY/T023">lung</z:mesh>, and both had fusion <z:mesh cui="C0029016" id="http://purl.bioontology.org/ontology/MESH/D009857" semantics="http://purl.bioontology.org/ontology/STY/T028">oncogenes</z:mesh> (NTRK1/TPR, n = 1; RET/PTC1, n = 1). CONCLUSIONS: Fusion <z:mesh cui="C0029016" id="http://purl.bioontology.org/ontology/MESH/D009857" semantics="http://purl.bioontology.org/ontology/STY/T028">oncogene</z:mesh> PTC presents with more extensive <z:mesh cui="C0012634" id="http://purl.bioontology.org/ontology/MESH/D004194" semantics="http://purl.bioontology.org/ontology/STY/T047">disease</z:mesh> and aggressive <z:mesh cui="C0220797, C0205469, C0243140, C0243139" id="http://purl.bioontology.org/ontology/MESH/Q000473" semantics="http://purl.bioontology.org/ontology/STY/T169, http://purl.bioontology.org/ontology/STY/T091, http://purl.bioontology.org/ontology/STY/T033">pathology</z:mesh> than BRAF(V) (600E) PTC in the pediatric <z:mesh cui="C0242445, C0032659" id="http://purl.bioontology.org/ontology/MESH/D011153" semantics="http://purl.bioontology.org/ontology/STY/T098, http://purl.bioontology.org/ontology/STY/T081">population</z:mesh>. The high <z:mesh cui="C0243130, C0376249, C0220920, C0220823, C0220880, C0243132, C0220856, C0220900, C0014508, C0220888" id="http://purl.bioontology.org/ontology/MESH/Q000453" semantics="http://purl.bioontology.org/ontology/STY/T079, http://purl.bioontology.org/ontology/STY/T169, http://purl.bioontology.org/ontology/STY/T081, http://purl.bioontology.org/ontology/STY/T170">prevalence</z:mesh> of the NTRK1/NTRK3 fusion <z:mesh cui="C0029016" id="http://purl.bioontology.org/ontology/MESH/D009857" semantics="http://purl.bioontology.org/ontology/STY/T028">oncogene</z:mesh> PTCs in the <z:mesh cui="C0041703" id="http://purl.bioontology.org/ontology/MESH/D014481" semantics="http://purl.bioontology.org/ontology/STY/T083">United States</z:mesh> is unusual and <z:mesh cui="C0039309, C0027552, C0018755, C0018756" id="http://purl.bioontology.org/ontology/MESH/D006301" semantics="http://purl.bioontology.org/ontology/STY/T098, http://purl.bioontology.org/ontology/STY/T080">needs</z:mesh> further investigation.
   </text>
</passage>
</document>
</collection>